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Background: Dementia is currently incurable, irreversible and a major cause of disability for the 
world’s older population. The association between mental health difficulties, such as Post Traumatic 
Stress Disorder (PTSD) and Major Depressive Disorder (MDD), and dementia has a long history within 
the civilian population. Despite the increased importance of this link within the military veteran 
population, who suffer a greater propensity of mental health difficulties and consist largely of over 
65’s, attention is only recently being paid to the salience of such an association for this group. This 
paper aims to explore the relationship between PTSD and MDD with dementia within the military 
veteran population.  
Method: A systematic review was conducted on articles from 1990 to July 2016 on MEDLINE, 
EMBASE, EBSCO and Web of Science electronic databases with an update conducted in February 
2017.  
Results: Six empirical studies were identified from the review, the majority of which originated from 
the US. Five of the studies asserted that veterans with a diagnosis of either PTSD or MDD are at a 
significantly greater risk of developing dementia than ‘healthy’ controls. The final study, conducted 
in Australia, found only a small, but non-significant, correlation between earlier MDD and future 
dementia, but no concurrent correlation.  
Conclusions: While causality cannot be determined, it is likely that PTSD and depressive disorders 
are related to an increased risk of dementia in military veterans. Potential pathological explanations 
and risk factors are reviewed and the clinical and neuroscience implications of these findings are 
explored. 
Keywords: Post-Traumatic Stress Disorder; Major Depressive Disorder; Dementia; Military; Mental 
Health Disorders; Review; Veterans 
1. Introduction  
1.1 Dementia  
Dementia is caused by degeneration of the brain and is characterised by symptoms such as memory 
loss, language difficulties and reduced problem solving ability (Alzheimer's Society, 2014). Dementia 
is irreversible and progressive meaning that symptoms continue to worsen throughout the patient’s 
life (Alzheimer's Society, 2014). There are many types of dementia but this paper will focus on the 
four most common types. These along with the associated neuro-degenerative pathways are 
highlighted in Table One below (Alzheimer's Society, 2014, British Medical Journal, 2017a, b, c, d, 
NHS, 2015): 
Table One: Neuro-degenerative Pathways to Dementia 
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Dementia Label Biological Pathway 
Alzheimer’s Disease 
Deposits of amyloid protein plaques and neurofibrillary tangles; brain atrophy; and 
neuronal degeneration  
Vascular Dementia 
A stroke or fatty deposits interrupt the blood supply to the brain interfering with the 
normal functioning; neuronal degeneration  
 Lewy Body Dementia 
Deposits of proteins develop inside brain cells impacting neurotransmitters 
carrying messages between brain cells 
Frontotemporal Dementia 
Temporal and frontal lobe damage, typically caused by a genetic mutation, 
causing the neuronal degeneration   
 
Alzheimer’s Disease is by far the most common form of dementia, estimated to account for up to 
70% of dementia cases (World Health Organisation, 2015). According to the Alzheimer's Society 
(2014) rates of dementia in the U.K. general population are estimated to be around 850,000, 
affecting 1 in every 14 people over the age of 65. Age is the biggest risk factor for dementia with the 
risk doubling every 5 years after the age of 65 (Alzheimer's Society, 2014).  
Dementia prevalence is increasing with the number of people living with dementia in the UK 
estimated to reach over 1 million by 2025, and over 2 million by 2050 (Lewis et al., 2014). This 
increase comes at both a personal cost to people with dementia and their families and carers but 
also a huge economic cost to the UK. The current financial cost of dementia to the UK economy is 
over £24 billion a year, this is a combination of health and care costs and the vast contribution made 
by informal carers (Lewis et al., 2014). We also know that people with dementia have a lower self-
reported quality of life than both the general population as a whole and those over 65 (Lewis et al., 
2014). 
1.2 MDD, PTSD and Dementia  
The relationship between MDD and dementia has been discussed within the civilian literature for 
many years, according to Mahendra (1985) potentially back to the ninth century AD. A 2006 meta 
analyses within the civilian population suggests that for those with a diagnosis of MDD there is an 
Odds Ratio of between 2.03 (95% CI: 1.73 -2.38) and 1.90 (95% CI: 1.55 – 2.33) for dementia, 
depending on whether case control or cohort studies are examined (Ownby et al., 2006). In addition 
to this, a recent review of the risk factors for dementia identified depression at any age, as well as 
late life depression, as two of the four core risk factors for dementia along with benzodiazepines use 
and frequency of social contact (Bellou et al., 2017). 
Whilst no comparable review exists exploring the relationship between PTSD and dementia within 
the civilian literature, empirical evidence is amassing which stresses the importance of this 
association across a range of populations. A study of 9/11 survivors found that current PTSD, as well 
as MDD diagnosis, was associated with a two fold increase in cognitive impairment (Clouston et al., 
2016). 12.8% of those screened displayed a level of cognitive impairment with 1.2% diagnosed with 
dementia, from a participant pool with an average age of only 53 these results are surprisingly high 
(Clouston et al., 2016). Holocaust survivors with PTSD have been shown to demonstrate accelerated 
aging compared to both holocaust survivors without PTSD and ‘healthy’ controls (Golier et al., 2002). 
A study exploring Swiss child labourers with PTSD indicated reduced cognitive function when 
compared to those without PTSD (Burri et al., 2013). 
1.2.1 Potential Pathways linking MDD/ PTSD and Dementia  
Butters et al. (2008) and Greenberg et al. (2014) provide concise overviews of the potential 
pathways between MDD and PTSD (respectively) with dementia. The following section will 
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summarise the complimentary pathways discussed in these reviews, supplemented by evidence 
from the wider literature. It must be stressed that these are not the only potential pathways, but 
rather they represent a number of pathways commonly discussed in the literature. It is also worth 
highlighting that the pathways are not mutually exclusive. 
1.2.1.1 Increased activation of the HPA  
MDD, PTSD and dementia are associated with hyperactivity of the hypothalamic-pituitary-adrenal 
(HPA) axis, and resultant increases in cortisol (Byers and Yaffe, 2014, Meziab et al., 2014, Qureshi et 
al., 2010, Veitch et al., 2013, Weiner et al., 2013, Yaffe et al., 2010). Increases in cortisol are shown 
to impact cognitive ability at the time of release as well as lead to cognitive impairment in later life 
(Meziab et al., 2014) with prolonged exposure to high levels of cortisol resulting in neuro-
degeneration (Byers and Yaffe, 2014, Meziab et al., 2014, Qureshi et al., 2010, Veitch et al., 2013, 
Weiner et al., 2013, Yaffe et al., 2010).  
1.2.1.2 Increased cytokines and resultant inflammation  
The HPA axis also controls the release of cytokines, proteins that impact certain neurotransmitters in 
the brain (Passmore, 2015). Increased levels of cytokines, seen in both MDD and PTSD, can cause 
inflammation which damages the brain and increases the risk of dementia (Byers and Yaffe, 2014, 
Veitch et al., 2013, Yaffe et al., 2010).  
1.2.1.3 Increase in Amyloid Beta plaques  
Amyloid Beta (Aβ) plaques are a diagnostic feature of Alzheimer’s Dementia (Byers and Yaffe, 2014, 
Weiner et al., 2013). Research indicates that MDD is also associated with an increase in Aβ 
deposition and that patients with both Alzheimer’s Dementia and MDD have an increased rate of Aβ 
deposition than those with Alzheimer’s Dementia alone (Byers and Yaffe, 2014, Veitch et al., 2013). 
PTSD has also been proposed to be caused by alterations of hormones which control the production 
and deposition of Aβ plaques (Sibener et al., 2014).  
1.2.1.4 Cognitive reserve  
The cognitive reserve theory states that PTSD and MDD may diminish cognitive reserve which may 
increase the risk, or speed up the process, of dementia (Apfel et al., 2011, Qureshi et al., 2010, 
Veitch et al., 2013, Yaffe et al., 2010). Higher levels of cognitive reserve, developed via factors such 
as higher socio economic status and educational attainment may ‘protect’ an individual from 
developing dementia (Dent et al., 1998). 
1.2.2 Potential Unifying Hypotheses 
1.2.2.1 Inflammatory Neuro-degeneration   
The theory of inflammatory neuro-degeneration is gaining traction as a potential explanation for the 
impacts of psychiatric conditions such as MDD and PTSD. This theory ties each of the above 
mechanisms together in a prospective ‘unifying hypothesis’. When the body is exposed to stress it 
triggers an inflammatory response as a form of protection (Boorman et al., 2015, Franklin et al., 
2015). Acute or prolonged stress can lead to increased inflammation and can result in neuro-
degeneration (Boorman et al., 2015, Franklin et al., 2015). The inflammatory response is controlled 
by the HPA axis and involves an increase in pro-inflammatory cytokines which in turn activate 
microglia (Boorman et al., 2015, Franklin et al., 2015). Among other processes, microglia activation 
leads to an increase in release of NLRP3 and inhibition of Brain Derived Neuro-trophic Factor (BDNF) 
both of which can result in neuro-degeneration (Boorman et al., 2015, Franklin et al., 2015). 
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Dementia is characterised by neuro-degeneration and both lower levels of BDNF and higher levels of 
NLRP3, stimulated by increased levels of Aβ plaques, are found in dementia (Boorman et al., 2015, 
Franklin et al., 2015). This suggests that such inflammatory markers may represent the mediatory 
factor between MDD/ PTSD and dementia (Boorman et al., 2015, Franklin et al., 2015). 
1.2.2.2 Brain reserve  
Butters et al. (2008) describe the theory of brain reserve in relation to dementia. Brain reserve 
theory is based on the notion that individuals can tolerate more or less cell loss before clinical 
symptoms are observed, based on their level of cell redundancy. Indeed a meta-analysis by 
Valenzuela and Sachdev (2006) found that higher levels of brain reserve were associated with a 
lower risk of dementia, Odds Ratio: 0.54 (CI: 0.49-0.59). Butters et al. (2008) suggest that such a 
hypothesis may also act as a ‘unifying hypothesis’ for each of the mechanisms described above, 
whereby each leads to an increasing level of reduction in brain reserve and therefore an increasing 
risk of dementia.  
In line with this theory Greenberg et al. (2014) highlight that it is important to remember that not 
everyone who is diagnosed with MDD or PTSD will develop dementia, rather it appears that 
conditions such as PTSD “play an ancillary role among numerous factors that are involved in 
pathogenesis of dementia” (pp. S163, Greenberg et al., 2014). The next section will explore how 
military veterans may represent a population at an increased risk of the pathogenesis of dementia 
due to a number of additional such factors. 
1.4 Increased Risk of Dementia for Military Veterans  
1.4.1 Increased prevalence of MDD and PTSD 
Common mental health disorders are reported to occur at an increased rate in military personnel 
compared to the general population. Indeed, within the UK  (Goodwin et al., 2015) found that the 
risk of common mental health disorders is approximately doubled in the military population as 
compared to the general population in employment (Odds Ratio of 1 versus an Odds Ratio of 2.4 
respectively). Rates of PTSD are also reported at higher rates in military personnel from the US 
(12.6%) and Australia (8.3%) (Hunt et al. (2014). Although the rate of PTSD in the UK Armed Forces is 
approximate to that in the general population (~4%), when military personnel deployed in combat 
roles are singled out prevalence rates increase to 5.7% (Fear et al., 2010). Therefore if, as civilian 
literature suggests, mental health conditions such as MDD and PTSD do represent risk factors for 
dementia, then military personnel, particularly those who have deployed, may represent a 
population with an increased vulnerability.  
1.4.2 Substantial aging population  
In addition to this, due to the influx of recruitment from World War II and National Service, 46% of 
the UK’s veteran population is over the age of 75, compared to only 10% of the general population 
(Royal British Legion, 2014). As mentioned earlier, age is the most significant risk factor for 
dementia, illustrating a further heightened risk factor for the veteran community over the general 
population.  
1.4.3 Metabolic syndrome 
Metabolic syndrome is a combination of obesity, high blood pressure and diabetes. Both 
hypertension and diabetes are postulated to interfere with Aβ clearance (Yaffe et al., 2014). As with 
obesity, although the prevalence of metabolic syndrome is not higher in the military population 
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when compared to the general population, the rate does increase in those in the military population 
with a mental health diagnosis (Yaffe et al., 2014).  
1.4.4 Physical inactivity  
Physical activity is also described as a potential preventative factor for dementia since it both 
increases neuro-genesis, as well as decreasing the risk of vascular disease and reducing inflammation 
(Yaffe et al., 2014). It has also been tentatively linked to lower levels of Aβ deposition in the brain 
(Yaffe et al., 2014). Again, Yaffe et al. (2014) propose that although the rates of physical activity in 
the veteran population is similar to the general population, there is some evidence of ‘retirement 
obesity’ for veterans who have previously held high levels of physical activity that are suddenly 
reduced when transitioning out of the military.  
1.4.5 Alcohol and Smoking  
Alcohol and smoking are also identified as risk factors of dementia that are more common in the 
veteran population than the general population (Veitch et al., 2013, Yaffe et al., 2014). Smoking 
presents an increased risk of dementia in many ways including: vascular disease; inflammation; 
accelerated reductions in the cerebral blood flow; cerebral atrophy and the formation of white 
matter lesions and can roughly double the risk of Alzheimer’s dementia (Veitch et al., 2013). For 
alcohol, although a low intake may be protective against dementia, excessive alcohol intake can be 
neuro-toxic thus increasing the risk of dementia (Yaffe et al., 2014).  
1.4.6 Traumatic Brain Injury 
One co-morbid condition that is frequently mentioned throughout the literature is Traumatic Brain 
Injury (TBI). TBI, is defined as “an external force to the head causes injury and results in alteration or 
loss or consciousness” (Sibener et al., 2014) and is said to increase the risk of dementia by between 
a two and four fold rate (Sibener et al., 2014). The rate of TBI is projected to be much higher in the 
military population compared to the general population due to the risk of TBI from Improvised 
Explosive Devices (IEDs) (Byers and Yaffe, 2014, Sibener et al., 2014, Veitch et al., 2013, Weiner et 
al., 2013). Rates of TBI after the recent Iraq and Afghanistan conflicts are assessed to be around 7% 
in US troops, although rates as high as 22% have been proposed, compared to around 0.5% in the 
general US population (Veitch et al., 2013). TBI has been proposed to interact with PTSD in three 
main ways: deposition of Aβ plaques and tau pathology; reduction in cognitive reserve; and ischemic 
lesions (Veitch et al., 2013).  
A link between mental health conditions such as MDD and PTSD with dementia holds a great deal of 
importance, especially for the veteran population who may be at an increased risk due the increased 
amplified prevalence of mental health problems as well as the heightened impact of a number of 
additional risk factors. This paper sets out to identify scientific literature examining the association 
between MDD, PTSD and dementia in the older veteran population. 
 
2. Method  
2.1 Search Strategy 
Relevant articles were identified by performing searches of the bibliographic databases MEDLINE, 
EMBASE, EBSCO, Web of Science, and Google Scholar. Searches included keywords: Dementia, 
Alzheimer Disease, depression, anxiety, Post-Traumatic Stress Disorder (PTSD), common mental 
disorders, alcohol & drug misuse, stress, military personnel, armed forces, and veterans. Searches 
were limited to studies in articles published between 1990 and July 2016, in the English language, 
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exploring the relationship between dementia and mental health in military veterans’. The full search 
strategy can be found in Appendix One. 
2.2 Selection Strategy 
A total of 130 articles were retrieved from bibliographic searches. 39 papers were removed as 
duplicates and a further 13 were rejected after reviewing paper titles. Abstract reviews were then 
conducted on the remaining 78 papers, removing a further 53 as irrelevant. The final 25 papers were 
read in full, of which 5 papers were deemed to be relevant to the search criteria. Hand searching 
was also conducted of all references cited in articles. This process was conducted by LAR with a 10% 
sample of abstracts and full papers blind reviewed by SAMS with any discrepancies discussed and 
resolved. An updated search, following the same protocol, was conducted in February 2017 which 
identified an additional paper for inclusion. The inclusion process is outlined below in Figure One. 
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Figure One: Inclusion Process 
Duplicates removed: n = 39
Papers rejected: n = 13
Not dementia AND mental health: n = 4
Not relationship betw een dementia and 
mental health: n = 2
Caregivers or family: n = 6
Female only: n = 1
Papers rejected: n = 53
Not dementia AND mental health: n = 17
Not relationship betw een dementia and 
mental health: n = 19
Treatment or intervention: n = 2
Caregivers or family: n = 3
Spanish language: n = 1
Abstract only (Conference poster): n = 8 
Not empirical study (Commentary or 
review ):  n = 3
Papers rejected: n = 20
Not dementia AND mental health: n = 9
Not relationship betw een dementia and 
mental health: n =2 
Treatment or intervention: n = 1
Not empirical study (case study or 
review ):        n = 7
Young onset dementia: n = 1
Titles reviewed: n = 91
Papers identified: n = 130
Papers identified via database 
searches: n = 130
Medline: n = 48
EMBASE: n = 56
EBSCO: n =4
WoS: n= 22
Papers included: n = 6 
Additional paper identified 
via updated search: n = 1
Full papers reviewed: n = 25
Abstracts reviewed: n = 78 
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2.3 Quality Appraisal 
A quality criteria assessment tool for cohort studies was used to rate the methodological quality of 
the studies (http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-
reduction/tools). LAR and SAMS rated the studies independently according to the quality criteria 
given. Any discrepancies were discussed and resolved. After scoring all the criteria, the different 
ratings were listed and a final overall rating for each study was given jointly (Appendix Two).    
2.4 Study Characteristics  
Five of the papers included in this review were retrospective cohort studies based on data drawn 
from the Department of Veteran's Affairs medical care system in the US. The studies identified 
eligible participants either aged 55 and over (Byers et al., 2012, Meziab et al., 2014, Yaffe et al., 
2010), aged 56 and over (Mawanda et al., 2017) or aged 65 and over (Qureshi et al., 2010). Each of 
the studies utilised the existing definitions for dementia and mental health diagnosis, namely the 
ICD-9 Clinical Modification, with information about the diagnoses drawn from medical records. The  
remaining paper was conducted in Australia with randomly selected veterans from World War II 
taking part in a prospective cohort study, aged between 65 and 85 years at the second phase (Dent 
et al., 1998). Depression and dementia were explored via a clinical interview, focused on the DSM 
criteria for MDD, and the DSM criteria for dementia, along with the Mini Mental State exam (Dent et 
al., 1998). The number of study participants ranged from 209 (Dent et al., 1998) to 417,172 
(Mawanda et al., 2017). All of the studies report that there were mental health diagnoses of either 
MDD or PTSD at a baseline point and then subsequent dementia diagnoses at a follow up point. Only 
the Australian study specifies that the diagnosis of PTSD/ MDD was still current at the follow up 
phase. Table Two below contains details of the characteristics of each paper reviewed and Table 
Three provides information on the dementia types explored within each study.  
Table Two: Characteristics of Included Papers 
Author 
Study 
Design 
Sample  Size 
Mental Health 
Classification  
Mental 
Health 
Diagnosis 
Mental 
Health 
Diagnosis 
Data 
Source 
Association  
Byers et 
al. (2012) 
Retrospective 
Cohort Study 
US 
veterans 
n = 
281,540 
ICD-9 Clinical 
Modification  
Major 
Depression 
Disorder 
Department 
of 
Veteran’s 
Affairs  
HR: 2.18 
(95% CI: 
2.08-2.28) 
55 years 
& over 
Dysthymia  
HR: 1.96 
(95% CI: 
1.71-2.25) 
Dent et 
al. (1998) 
Prospective 
Cohort Study 
Australian 
veterans 
n = 209 
DSM Criteria  
Major 
Depressive 
Disorder/ 
Other 
Depression 
Clinical 
Interview 
R: 0.13 
(95% CI: 
0.00-0.26) 
56 years 
& over 
Zung 
Depression 
Scale 
Depressive 
symptoms  
R: 0.16 
(95% CI: 
0.02-0.29) 
Mawanda 
et al. 
(2017) 
Retrospective 
Cohort Study 
US 
veterans 
n = 
417,172 
ICD-9 Clinical 
Modification  
PTSD 
Department 
of 
Veteran’s 
Affairs 
HR: 1.35 
(95% CI: 
1.27-1.43) 
PTSD + 
Psychotropic 
Medication 
(SSRI)  
HR: 1.99 
(95% CI: 
1.72-2.29) 
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PTSD + 
Psychotropic 
Medication 
(SNRI)  
HR: 2.02 
(95% CI: 
1.78-2.30) 
56 years 
& over 
PTSD + 
Psychotropic 
Medication 
(AAI)  
HR: 4.21 
(95% CI: 
3.72-4.76) 
Meziab et 
al. (2014) 
Retrospective 
Cohort Study 
US 
veterans 
n = 484 
ICD-9 Clinical 
Modification  
PTSD Department 
of 
Veteran’s 
Affairs  
HR: 1.52 
(95% CI: 
1.41-1.64) 
55 years 
& over 
PTSD + 
POW 
HR: 2.24 
(95% CI: 
1.72-2.92) 
Qureshi 
et al. 
(2010) 
Retrospective 
Cohort Study 
US 
veterans 
n = 
10,481 
ICD-9 Clinical 
Modification  
PTSD Department 
of 
Veteran’s 
Affairs  
OR: 2.2 
(95% CI: 
1.8-2.6) 
65 years 
& over 
PTSD + 
Purple Heart 
OR: 1.4 
(95% CI: 
0.7-2.7) 
Yaffe et 
al. (2010) 
Retrospective 
Cohort Study 
US 
veterans n = 
181,093 
ICD-9 Clinical 
Modification  
PTSD 
Department 
of 
Veteran’s 
Affairs  
HR: 2.31 
(95% CI: 
2.24-2.39) 55 years 
& over 
 
Table Three: Types of Dementia explored in Included Papers 
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Alzheimer's Disease             
Vascular Dementia             
Lewy Body Dementia              
Frontotemporal Dementia              
Senile Dementia             
Dementia not otherwise specified              
Alcohol induced Dementia             
Drug induced Dementia             
Parkinsons             
Other degenerative diseases of the basal ganglia             
Dementia due to Huntingtons disease             
Dementia due to Jakob-Creutzfeldt disease             
Dementia due to Multifocal leukoencephalopathy (Encephalitis)             
Dementia in conditions classified elsewhere e.g. physical condition              
 
The majority of papers focused on the four most common types of dementia, as illustrated in Table 
One, as well as a more generic dementia category (Byers et al., 2012, Mawanda et al., 2017, Meziab 
et al., 2014, Yaffe et al., 2010). Qureshi et al. (2010) provide the most comprehensive categorisation 
of dementia covering a far broader range of dementia types than the other studies reviewed (Table 
Three). 
3. Findings 
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3.1 Dementia and MDD 
Byers et al. (2012) explored both MDD and dysthymia, which they defined as a depressive spectrum 
diagnosis, in veterans with no evidence of dementia at a study baseline point between 1997 and 
2000 (n=281,540). At a follow up point between 2001 and 2007, after adjusting for demographics 
and comorbidities, veterans diagnosed with dysthymia or MDD were twice as likely to develop 
dementia compared with those with no dysthymia or MDD (Byers et al., 2012). The research of Byers 
et al. (2012) provides evidence for an association between the larger spectrum of depressive 
disorders and an increased risk of dementia in older veterans.  
Dent et al. (1998) also explored the relationship between MDD and dementia, as well as 
investigating lower levels of depressive symptoms and cognitive decline. Veterans from World War 
II, living in Sydney, were tested in 1982 and again in a follow up session in 1991 (n=209). The results 
of the study found that the association between depressive symptoms and poor cognitive 
performance could be explained by the impact of verbal intelligence, a measure deemed resistant to 
the effects of brain pathology. Although a small correlation was found between MDD in 1982 and 
dementia in 1991, this was not statistically significant (r=0.13, CI: 0.00-0.26) and no concurrent 
correlation was found between MDD in 1991 and dementia in 1991. The lack of a significant 
difference in the prevalence of dementia in those with and without MDD at baseline led the authors 
to conclude that MDD was not a predictor of dementia (Dent et al., 1998). 
3.2 Dementia and PTSD 
Exploring the relationship between PTSD and dementia Yaffe et al. (2010) found that US veterans 
(n=181,093) with a diagnosis of PTSD at baseline were significantly more likely to have a diagnosis of 
dementia at a follow up period (roughly seven years later), than those without a diagnosis of PTSD.  
Qureshi et al. (2010) explored the association between dementia and PTSD in US veterans over the 
age of 65 (n=10,481). Four groups of participants were identified: 1) a control group, 2) a group with 
a PTSD diagnosis 3) a group with a Purple Heart (a medal presented to veterans physically wounded 
in combat which they used as a proxy for combat exposure) and 4) a group with both PTSD and a 
Purple Heart. Veterans with PTSD and no Purple Heart were twice as likely as those without PTSD 
and no Purple Heart, or those without PTSD and a Purple Heart to develop dementia. This study 
allows the distinction to be made between the impact of combat exposure and PTSD, showing PTSD 
to represent the more substantial risk for dementia (Qureshi et al., 2010).  
Meziab et al. (2014) investigated the relationship between PTSD and dementia as well as the impact 
Prisoner Of War (POW) status may have on this relationship (n=484). Adjusting for demographics, 
medical and psychiatric comorbidities, period of service, and the competing risk of death, there was 
an increased risk of more than 50% for dementia in POWs, an increased risk of more than 50% for 
dementia in those with PTSD and those veterans with both PTSD and POW status were twice as 
likely to develop dementia (Meziab et al., 2014). Meziab et al. (2014) suggest that the additive effect 
of PTSD and POW status found in their study may indicate that the underlying mechanisms behind 
the impact of each status on dementia are different, presenting POW status as an additional risk 
factor pertinent to the veteran community.   
Mawanda et al. (2017) examined the association between PTSD and dementia, as well as the 
potential impact of psychotropic medication use on this relationship in US veterans (n=417,172). 
Those veterans with a diagnosis of PTSD at baseline (2002-2003) were significantly more likely to 
have a diagnosis of dementia during the follow up period (2004-2012) (Mawanda et al., 2017). The 
authors found that psychotropic medication use impacted this association, specifically those 
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veterans with a diagnosis of PTSD and a history of specific psychotropic medication use (SSRIs, 
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and atypical antipsychotics (AAs)) were 
significantly more at risk of dementia than those with a diagnosis of PTSD and no history of 
psychotropic medication use (Mawanda et al., 2017). In addition to this Mawanda et al. (2017) found 
that use of specific psychotropic medication at baseline (benzodiazepines (BZAs) or SNRIs) lead to a 
significantly increased risk of dementia at follow up, independent of PTSD diagnosis. This suggests 
that use of specific psychotropic medications may act as an additional risk factor for dementia 
(Mawanda et al., 2017).  
Figure Two: Forest Plot of MDD, PTSD and Dementia 
As indicated in Figure Two the relationship between PTSD and dementia appears to be supported by 
the papers included in this review. Further research is required to ascertain the relationship 
between MDD and dementia and to understand the different results in the papers included in this 
review.  
4. Discussion  
4.1 Overview of Results  
The review identified six papers which discussed either MDD or PTSD, and dementia in military 
veterans, published in peer reviewed journals. Despite the studied participants originating from the 
US or Australian military, given the neuro-biological nature of dementia, the results should hold 
relevance to the Armed Forces worldwide.  
The initial hypothesis for this paper was that suffering MDD/ PTSD resulted in an increased risk of 
dementia in military veterans. This review found a significant association between PTSD and a later 
diagnosis of dementia which supports the assertion that a diagnosis of PTSD increases the risk of 
dementia in military veterans. The relationship between MDD and dementia illustrates conflicting 
results with one study supporting the relationship (Byers et al., 2012) and another denying it (Dent 
et al., 1998). 
Dent et al. (1998) is the only paper which does not support the relationship between MDD/ PTSD 
and dementia. There are a number of potential reasons for this variation. The Dent et al. (1998) 
study is the only study which employs a prospective as opposed to retrospective design. Prospective 
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designs are thought to provide more accurate measures of risk, with less potential bias and 
confounding variables, so it may be that the non-significant relationship between MDD and 
dementia found in the Dent et al. (1998) study represents the more accurate finding. The Dent et al. 
(1998) study is also the only study that utilised clinical interviews to diagnose both MDD and 
dementia and thus its results may well be more valid than those drawing diagnoses from medical 
records. However, the Dent et al. (1998) study employed a comparatively small sample size of 209, 
compared to sample sizes in the 100,000s for the majority of the VA studies potentially impacting 
the power of its findings. The Dent et al. (1998) study is also the only study which was conducted 
outside of the US suggesting that there may be a cultural confounder at play, possibly in terms of the 
application of diagnostic criteria.  
Within the civilian literature an odds ratio of between 1.90 (95% CI: 1.55 – 2.33) and 2.03 (95% CI: 
1.73 -2.38) was identified in Ownby et al. (2006) meta-analyses for MDD and dementia. This is 
comparable to results of Byers et al. (2012) where a hazard ratio of 2.18 (95% CI: 2.08 – 2.28) was 
found. The outlier is Dent et al. (1998) study where no significant risk was identified.  
4.2 Proposed explanations for findings 
The research studies included in the review provided limited potential explanations for the 
mechanisms behind the association between MDD/ PTSD and dementia. Table Four below illustrates 
the pathways discussed within the papers. 
Table Four: Neuro-biological Pathways 
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HPA: Cortisol             
Cytokines: Inflammation             
Aβ plaques             
Cognitive Reserve             
 
Although there is limited discussion in the reviewed papers on the pathways that may link MDD/ 
PTSD and dementia, what discussion there is supports both the inflammatory neuro-degeneration 
hypothesis and the notion of brain reserve.  
Evidence supporting both hypotheses is also present in the majority of papers included in the 
review. Byers et al. (2012) illustrate that dysthymia, as well as MDD, increases the risk of dementia. 
Mawanda et al. (2017) found that psychotropic medications also increase the risk of dementia. Since 
both dysthymia, and psychotropic medications, also impact neuro-inflammation this provides 
further support for the theory that inflammation is at the root of the association between MDD/ 
PTSD and dementia.  
Additional risk factors that separately increase the risk of dementia in military veterans are found in 
three of the papers reviewed here. Meziab et al. (2014) conclude that POW status increases the risk 
of dementia, Mawanda et al. (2017) illustrate that psychotropic medications can increase the risk of 
dementia and Qureshi et al. (2010) show that Purple Heart status, indicative of combat exposure, 
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also increased the risk of dementia. Each of these additional risk factors supports the notion that 
dementia risk may steadily increase as each additional risk factor depletes individuals’ brain reserve.  
It could be assumed that from the plethora of additional risk factors the military veteran population 
face that their risk of dementia should be heightened over the civilian population. Although current 
rates of dementia in the military population appear to be no higher than the general population, at 
least with regard to the US military population (Sibener et al., 2014), it would be expected that 
increasing rates of PTSD and MDD with recent deployments would lead to an increased ‘future’ rate 
of dementia in the future veteran population. In line with the work of Butters et al. (2008) it may be 
that each of these risk factors reduces the veterans’ brain reserve, continuing to steadily increase 
their risk of dementia. If we take a similar stance then the risk for military veterans is not only 
dramatic but also highly complex. We suggest that future research should aim to unpack the 
pathways and mechanisms involved, as well as identify if and how these pathways are inter-related, 
in order to begin to understand the increased risk for this population. 
4.3 Limitations 
 
4.3.1 Retrospective Cohort Studies  
The research presented here cannot identify causality; no conclusions can be drawn as to whether 
MDD and PTSD cause dementia or whether another factor causes both mental health conditions.  As 
mentioned earlier, prospective studies are needed to provide more accurate measures of risk, with 
less potential bias and confounding variables. 
4.3.2 Diagnostic Method Variability  
As Meziab et al. (2014) highlight, studies that draw data from VA records draw from records kept for 
medical and billing purposes and as such may hold some misrepresentations. Dent et al. (1998) is 
the only study where the reader is provided details of how the diagnoses were made. As such we are 
unable to ascertain, but may assume, that there is a degree of diagnostic method variability between 
the studies, at least between the Dent et al. (1998) study and the VA studies.  
4.3.3 Relevance to UK Military Veterans  
The limited available evidence supports an association between PTSD and MDD with dementia 
within military veterans in the US. All of the retrospective cohort studies reviewed in this paper were 
based on data from the Department of Veteran’s Affairs medical care system in the US and as such 
are limited to those who utilise this service (Byers et al., 2012, Krishnan et al., 2005, Meziab et al., 
2014, Qureshi et al., 2010, Yaffe et al., 2010). Such research may hold questionable salience in the 
UK where rates of mental health difficulties in military personnel vary substantially from the US. 
Empirical evidence exploring this association within UK military veterans, as well as the causal 
pathways underlying this relationship, is needed. 
4.3.4 Potential Confounding Variables 
Qureshi et al. (2010) also highlights that VA studies are unable to collect additional data that may 
have been influential, such as the duration, severity, or treatment of PTSD/ MDD which may have 
impacted the dementia diagnosis. 
4.3.5 Lack of Neurological Data 
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The studies based on the VA were unable to collect any neurobiological information, such as 
inflammatory markers (Byers et al., 2012, Krishnan et al., 2005, Meziab et al., 2014, Qureshi et al., 
2010, Yaffe et al., 2010).  
4.3.6 Systematic Review Process 
Although a 10% sample of the abstracts for review were also screened by an independent author, 
the robustness of the review could have been improved if the entire review process was conducted 
by two independent authors.  
4.4 Implications 
4.4.1 Research Implications  
We are still unable to prove, or explain, whether PTSD or MDD are risk factors for dementia within 
the UK, or worldwide, military veteran population. A large scale cohort study is needed to assess UK 
military veterans’ MDD/ PTSD and dementia status over a significant period of time, including the 
capturing of neuro-biological markers and the use of brain imaging to understand the mechanisms 
underlying such an association. Such studies should be replicated to enable an appreciation of the 
risk to veterans worldwide. In addition to this further, small scale studies could be conducted to both 
measure neuro-biological markers and test the potential impact of additional risk factors on the 
prevalence of dementia. 
4.4.2 Military Implications 
It is understandable that much of the military mental ill-health research carried out to date is 
conducted with a focus on the here and now, and near future. However, the findings of this review 
supports taking a longer-term view, and the mental well-being of older veterans, especially in terms 
of dementia/Alzheimer’s disease, should be considered. Whilst the onset of dementia cannot be 
currently predicted with any great accuracy (aside possibly from the genetic factors), nor the 
inevitable slow decline in cognitive functioning associated with the condition be alleviated, it may be 
possible to highlight veterans who may be at higher risk, and hence provide timely and measured 
support accordingly.  
The evidence available to date which indicates that the veteran population is at heightened risk of 
developing dementia over the general population is highly relevant for the future care of military 
veterans. Should this potential increased risk be confirmed, then care provisions for veterans with 
dementia will need to be prioritised to some degree to ensure consistency with the Military 
covenant promise (Ministry of Defence, 2015). Further research is therefore required to identify 
whether the findings in this review of mainly US papers, hold true for UK veterans and indeed 
veterans worldwide. 
4.4.3 Clinical Implications 
The inflammatory neuro-degeneration hypothesis cites inflammation at the centre of the association 
between MDD/ PTSD and dementia. If proven this would have far-reaching clinical implications for 
the treatment of all three conditions. In addition to this anti-inflammatory medication may in fact 
help to mediate any potential relationship between conditions reducing the risk of dementia.  
5. Conclusion  
This review concludes that current evidence suggests that the military veteran community are at an 
increased risk of dementia due to the increased prevalence of mental health conditions such as PTSD 
and MDD within this population, as well as the supplementary impact of other military risk factors 
on this association. With the myriad of potential risk factors faced by military veterans it seems likely 
that the additive, complex interaction of all these factors impacts the development of dementia. 
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Both the theory of inflammatory neuro-degeneration and the brain reserve hypothesis hold 
potential in explaining this multifaceted relationship.  
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